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An Exploratory Analysis of Cross-
Country Access to Antiretroviral 
Treatment1  
The past five years have seen a groundswell of public opinion and policy in 
favour of expanding access to highly active antiretroviral therapy (HAART) in 
developing countries.  Important milestones in this regard have been the launch 
of the $15 billion United State’s President’s Emergency Plan for AIDS Relief 
(PEPFAR) and the announcement on World AIDS Day 2003 by the World 
Health Organisation and UNAIDS of a concrete plan to provide HAART to 
three million people by the end of 2005.  Key elements of this ‘three by five’ 
strategy include developing country-level support and capacity building, 
harnessing additional donor funding and ensuring a cost-effective and reliable 
supply of medication.2   
This unprecedented international effort has resulted in dramatic increases in the 
numbers of people accessing HAART in developing and transitional countries.  
Between June 2004 and December 2004, the number of people on HAART 
more than doubled in Sub-Saharan Africa and the developing and transitional 
country total rose from 400,000 to 700,000 (see Table One).  But whilst 
recognising the centrality of this international mobilisation in favour of greater 
HAART coverage, UNAIDS and the World Health Organisation are at pains to 
stress that success will “ultimately depend on continued strong commitment and 
follow-through by governments”.3     
Governments clearly play a central role in determining country-level access to 
HAART.  This is illustrated vividly by the contrasting cases of three high HIV 
prevalence neighbouring Southern African countries at similar levels of 
development:  Botswana (adult HIV prevalence of 37 percent), Namibia (21 
percent) and South Africa (22 percent).  Whereas by the end of 2004, Botswana 
had succeeded in providing HAART to 50 percent of those estimated to need it, 
                                                 
1 I am grateful to Jim Levinsohn, Martin Wittenberg and Ali Tasiran for their comments on 
earlier drafts and to Tom Scott for his research assistance. 
2 Details of the ‘three by five’ initiative’ can be found on http://www.who.int/3by5. 




and Namibia had reached 28 percent respectively, South Africa had provided 
HAART to a mere seven percent of those living with AIDS.  AIDS prevention 
and treatment policies are political priorities in Botswana and Namibia, but are 
mired in confusion and political dissembling in South Africa (Nattrass, 2004; 
Phororo et al, 2004; WHO, 2005).     


































310,000 4,000,000 8% 150,000 12.9% 
Latin America 
and the Caribbean 
275,000 425,000 
 
65% 220,000 3.9% 









10% 11,000 5.3% 
North Africa and 
the Middle East 
4,000 55,000 7% 4,000 0% 
Total 700,000 5.8 million 12% 440,000 9.8% 
Note: * Average of low and high estimate. 
Source:  WHO (2005: 11). 
However, political commitment is far from the only reason why AIDS-affected 
developing countries are likely to differ in terms of HAART coverage.  Factors 
such as resource availability, institutional characteristics and the scale of the 
epidemic are also likely to be relevant.  It is thus instructive to examine the 
international data to see if empirical regularities exist which might help 
‘explain’ the cross-country distribution of HAART coverage.   
This paper investigates some possible determinants of HAART coverage 
through exploratory regression analysis using data from World Health 
Organisation (2005), UNAIDS and the World Bank.4  Following UNAIDS and 
the World Health Organisation, HAART coverage is defined as the number of 
                                                 
4 Data from the World Bank are available on www.worldbank.org.  AIDS-related data are 
available from the World Health Organisation (www.who.int) and via links on the UNAIDS 
website (www.unaids.org).   
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adults on HAART expressed as a percentage of the number estimated to need it 
in each country. The bulk of the empirical work was conducted using HAART 
coverage as of December 2004.  However, in order to highlight how the 
international effort to improve access to HAART has changed the situation, 
regression analysis on HAART coverage as of June 2004 is also included at key 
points in the paper for comparative purposes.  
1. The Promise of HAART 
AIDS is overwhelmingly concentrated in developing countries.  Eighty-three 
low- and middle-income countries collectively account for 90 percent of the 
37.5 million people estimated by UNAIDS to be living with HIV/AIDS 
worldwide at the end of 2004.  Most of these are in poor countries, with Sub-
Saharan Africa, China and India accounting for 75 percent of global HIV 
infections.  One of the reasons for this pattern is that poverty is strongly 
implicated in HIV transmission (see e.g. Booysen 2002; Baylies and Burja, 
2001; UNAIDS/WHO, 2004; Stillwaggon, 2002).  The situation is aggravated 
by inadequate health care (itself a function of low levels of development) and 
weak or belated political responses to the AIDS crisis.      
As can be seen in Figure One, life expectancy has been declining sharply in 
AIDS-affected countries – particularly those in Southern Africa. For those 
countries where HIV prevalence is in excess of five percent, life expectancy in 
2002 is now lower than it was in the 1960s.  No wonder then, that De Waal 
describes the AIDS pandemic as a “development processes run in reverse” 
(2003: 11).   
As illustrated in Figure Two, a large-scale HAART programme together with a 
set of AIDS prevention interventions (voluntary counselling and testing, mother-
to-child-transmission-prevention and the improved management of sexually 
transmitted diseases) can have a large positive impact on life expectancy.  This 
projection for South Africa comes from the ASSA2000 Interventions Model’s 
estimation of the likely demographic impact of different hypothetical large scale 
interventions designed to reach 90 percent of those who need them by 2006 (see 
Johnson and Dorrington, 2002; Geffen et al, 2003; Nattrass, 2004).  The model 
draws on behavioural research from developed and developing countries (e.g. 
De Vincenzi, 1994; VTCESG, 2000) and medical research showing that people 
on HAART have lower viral loads and hence are less infectious (see e.g. 
Vernazza, et al, 2000; Hart et al, 1999).  It predicts that adding a large-scale 
HAART ‘rollout’ to a set of AIDS prevention interventions has a significant 
positive impact on life expectancy – both by extending the lives of those living 
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with AIDS and preventing new HIV infections.5 Such a large beneficial impact 
of improved access to HAART on life expectancy is likely to materialise also in 
other high HIV prevalence Southern African countries.  Countries with lower 
levels of HIV prevalence will also experience benefits in terms of longer life 
expectancy for AIDS patients and fewer new HIV infections, but as this comes 
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Figure One:  Life Expectancy at Birth for AIDS-affected countries 
(population-weighted average by region) 
 
                                                 
5 Marseille et al (2002), however, caution against concluding that HAART helps prevent new 
HIV infections. They warn that the preventative benefits of reduced viral load have to be 
balanced against longer life expectancy for people on HAART. The ASSA model addresses 
this concern by assuming that HAART patients remain sexually active throughout their 
extended lives.  In other words, the model predicts that the positive effects of reduced 
infectivity on HIV incidence overwhelm the negative effects of longer life of sexually active 
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Figure Two:  The Projected Impact of Large-Scale Prevention-only and 
Prevention and Treatment Interventions on Life Expectancy in South 
Africa (ASSA2000 Interventions Model).  
It is now widely accepted that more people are likely to participate in voluntary 
counselling and testing if there is hope of treatment (see e.g. Harvard Consensus 
Statement, 2001; De Cock et al, 2002).  This has proved to be the case in Haiti 
(Farmer et al 2001) and in Khayelitsha, Cape Town (Coetzee and Boulle, 2003). 
In other words, implementing a HAART programme is likely to have additional 
benefits beyond those reflected in the modelling exercise underpinning Figure 
Two by creating a social environment less conducive to the spread of HIV than 
would be the case in the absence of treatment possibilities.          
According to the most recent estimates, only 12 percent of people living with 
AIDS in developing and transitional countries are actually receiving it (see 
Table One).  However, as can be seen in Figure Three, there is a wide 
discrepancy in country-level achievement in this regard.  The remainder of the 
paper explores possible determinants of this cross-country pattern using ordinary 
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Figure Three.  HAART Coverage (December 2004) and GNP Per Capita 
(2002) 
2.  What Determines HAART Coverage? 
Given that per capita income is an obvious proxy for the level of social 
resources available for providing and facilitating access to HAART, one would 
expect, ceteris paribus, that the higher the level of per capita income, the greater 
will be the level of HAART coverage.  This is borne out in Figure Three which 
shows a simple linear relationship between per capita income and HAART 
coverage for 77 transitional and developing countries.6  The relationship is 
                                                 
6 The World Health Organisation’s (2005) best estimate of HAART coverage was available 
for the following countries: Angola, Argentina, Barbados, Belize Benin, Bolivia, Botswana, 
Brazil, Burkino Faso, Burundi, Cambodia, Cameroon, Central African Republic, Chile, 
China, Columbia, Costa Rica, Cuba, Cote de’Ivoire, Democratic Republic of the Congo, 
Djibouti, Dominican Republic, Ecuador, El Salvador, Ethiopia, Gabon, Gambia, Ghana, 
Guatemala, Guinea, Guyana, Haiti, Honduras, India, Indonesia, Jamaica, Kazakhstan, Kenya, 
Latvia, Lesotho, Madagascar, Malawi, Mauritania, Mexico, Mozambique, Myanmar, 
Namibia, Nepal, Nicaragua, Nigeria, Paraguay, Peru, Russian Federation, Rwanda, South 
Africa, Sri Lanka, Suriname, Swaziland, Thailand, Togo, Trinidad and Tobago, Uganda, 
Ukraine, United Republic of Tanzania, Uruguay, Uzbekistan, Venezuela, Vietnam, Zambia, 
Zimbabwe.  HAART coverage was estimated for the Malaysia and Senegal by expressing the 
average of the high and low estimate of the number of people on HAART as a percentage of 
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clearly affected by strong positive outliers (especially from Latin America and 
the Caribbean) and negative outliers (such as Russia and South Africa).  
Regression 2.1 in Table Two presents the simple relationship in logged form.  It 
predicts that a 10 percent increase in per capita income will be associated with a 
9.2 percent increase in HAART coverage.   
Table Two: Resource Constraints and HAART Coverage 
Dependent variable:  Log of 
HAART coverage (December 2004) 
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Adjusted R-squared 0.3456 0.3937 0.2951 0.4124 0.3355 0.4060 
Number of observations 77 77 73 73 73 73 
Notes: * Significant at the 10% level, ** significant at the 5% level, *** significant at the 1% level. 
                                                                                                                                                        
the number estimated to be needing HAART – data obtained from WHO (2005).  HAART 
coverage for the remaining countries were estimated by taking the UNAIDS estimate for the 
numbers needing HAART in 2004 (from the UNAIDS website: www.unaids.org) as a 
percentage of the World Health Organisation’s (2005) estimate of the numbers needing 
HAART: Chad, Congo, Egypt, Eritrea, Iran, Liberia, Mali, Niger, Pakistan, Papua New 




One could also reasonably suppose that HAART coverage is likely to be a 
function of the allocation of national resources (both public and private) to 
health care.  Regression 2.2 includes a variable that expresses the total amount 
spent per capita on health in each country as a percentage of per capita income.  
This increases the explanatory power of the model and reduces the impact of per 
capita income slightly.  The regression predicts that, controlling for the level of 
development (as proxied by per capita income), an increase of one percent in the 
share of health spending per capita will be associated with a 16 percent increase 
in HAART coverage.     
Access to health services is also likely to affect HAART coverage.  Regressions 
2.3 to 2.6 include a variable measuring the percentage of births attended to by 
health professionals as this could be thought to be a reasonable proxy for the 
reach of the health sector.  But while it is indeed significant in specifications that 
do not control for per capita income (regressions 2.3 and 2.5), its significance 
falls away in specifications that do (regressions 2.4 and 2.6).  This is because per 
capita income is strongly correlated with the percentage of births attended to by 
skilled medical personnel (correlation coefficient of 0.73).  The same 
relationship is evident between per capita income and another potential proxy 
for government capacity that has been included in regressions 2.5 and 2.6: the 
World Bank’s index of government effectiveness.  This variable, which has a 
correlation coefficient of 0.78 with per capita income, has a statistically 
significant coefficient when per capita income is excluded (regression 2.5) but 
not when per capita income is included (regression 2.6).  It would seem, then, 
that per capita income is capturing both the availability of resources as well as 
government capacity to provide and facilitate greater HAART coverage.    
Although HAART has been widely available in the advanced capitalist countries 
since the mid-1990s, the very high initial price of HAART limited its early use 
in most developing countries (the notable exception being Brazil which opted to 
challenge existing patent rights by producing and importing generic medication).  
Although some countries were more proactive than others in seeking foreign 
assistance to provide HAART and negotiating discounts with pharmaceutical 
companies prior to the wide-spread price declines (e.g. Botswana), it is 
nevertheless to be expected that for the same amount of effort, a country with a 
relatively low level of HIV prevalence would have been able to achieve a much 
higher HAART coverage than a country starting a HAART initiative with a 
relatively high HIV prevalence.  It thus seems appropriate to control for this 
timing issue by including the level of adult HIV prevalence into the regression.   
However, since the early 2000s, competition from generic producers in India 
combined with public pressure on pharmaceutical companies and various high-
level initiatives (including by ex-President Clinton) has resulted in sharp 
 9
declines in the price of HAART in most countries (Lucchini et al, 2003; Nattrass 
and Geffen, 2005).  This, together with substantial international support and 
assistance with regard to the provision of HAART in high HIV prevalence 
countries, is likely to have counteracted the initial disadvantage experienced by 
high prevalence countries.  One would thus expect the negative impact of the 
scale of the HIV/AIDS epidemic to disappear over time.     
Regressions 3.1 and 3.3 in Table Three explore this proposition.  Regression 3.1 
includes the (log of) adult HIV prevalence in a regression on HAART coverage 
as of June 2004, 7 and regression 3.3 runs the same model but this time on 
HAART coverage as of December 2004.  Whereas adult HIV prevalence 
exercises a significant negative effect on coverage in June 2004, this effect had 
disappeared entirely by December 2004.  This is consistent with the proposition 
that by December 2004, the initial disadvantage posed by high HIV prevalence 
had been offset by targeted international support.  If so, then it would be 
unnecessary (and inappropriate) to control for the scale of the epidemic in 
regression models based on December 2004 data.    
As suggested by Table One, there are good reasons to suspect that regional 
effects matter when determining the percentage on HAART.  In their cross-
country study of budgeting for HIV/AIDS, Guthrie and Lara conclude that 
governments in Latin America put more emphasis on HAART interventions 
than is the case in Africa (2005: 335-6).  This is consistent with the pattern of 
country-level access to HAART.  As can be seen in Table One, average HAART 
coverage is much higher in Latin America and the Caribbean than in any other 
region.  In an attempt to capture regional effects, the regressions reported in 
Tables Three and Four include dummy variables for Sub Saharan Africa and 
Latin American and Caribbean countries.  As expected, the results show that 
after controlling for other relevant variables, the effect of being a Latin 
American or Caribbean country significantly boosts the percentage on HAART.  
More surprising, perhaps, is the fact that the coefficient on the Sub Saharan 
African dummy is significant and positive.  This implies that although HAART 
coverage is low in Sub-Saharan Africa, it is nevertheless higher than predicted 
once other relevant factors are controlled for.  In other words, it would certainly 
be a mistake to attribute Sub-Saharan Africa’s low mean HAART coverage 
relative to Latin America and the Caribbean as being a reflection of government 
prioritisation of prevention over treatment.  Rather, it suggests that by December 
2004, Sub-Saharan African countries had succeeded in getting more people on 
                                                 
7  HAART coverage in June 2004 was estimated by expressing the UNAIDS estimate for the 
numbers of people on HAART as of June 2004 as a percentage of the number of people 




HAART than would be predicted given the institutional and economic 
characteristics controlled for in Tables Three and Four.   
Note that the significance of the Sub-Saharan African dummy variable for the 
regression run on HAART coverage in June 2004 is dependent on controlling 
for the scale of the epidemic.  When the (log of) adult HIV prevalence is left out 
of the model (regression 3.2), the Sub-Saharan African dummy becomes 
insignificant (and the sign changes direction).  In other words, if as of June 2004 
we did not take into account the disadvantages posed by already-existing high 
levels of HIV prevalence for Sub-Saharan African countries, then the fact of 
being located in Sub-Saharan Africa did not exercise a significant impact on 
HAART coverage.  However, six months later, Sub-Saharan Africa appears to 
have overcome the disadvantages posed by their relatively high levels of HIV 
prevalence to such an extent that being located in Sub-Saharan Africa has a 
significant positive impact on HAART coverage even in the absence controlling 
for the scale of the epidemic.    
The analysis so far has demonstrated the importance of the level of per capita 
income for HAART coverage.  But while the level of per capita income gives an 
indication of the resources available, it says nothing per se about the distribution 
of resources within the country.  Could it perhaps be the case, even after 
controlling for per capita income, that within-country inequality has an effect on 
the percentage on HAART?  One might hypothesise that if HIV prevalence is 
concentrated amongst the poor, then elite groups in high inequality societies 
may, out of narrow self-interest, prefer social resources to be allocated to 
priorities other than HAART.  This scenario has been argued to be the case in 
South Africa (Nattrass, 2004).  Does this supposition hold more generally?   
Table Three explores the relationship between HAART coverage and within-
country inequality.  Regression 3.3 serves as the base-line comparison.  This 
regression does not try and control for inequality, but simply includes regional 
dummy variables for Sub-Saharan Africa and Latin America and the Caribbean, 
the log of per capita national income and the share of per capita income spent on 
health.  The sign and significance of the economic variables (per capita income 
and share of expenditure on health) are as expected given our earlier analysis 
and both regional dummies are positive and significant.    
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Table Three: HAART Coverage and Inequality 
 HAART coverage 
in June 2004 
HAART coverage in December 2004 
Dependent variable:  Log 
of HAART coverage 
3.1 3.2 3.3 3.4. (only 
those 
countries 
with data on 
inequality) 
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Adjusted R-squared 0.5470 0.5064 0.5334 0.4652 0.4566 0.4431 0.4617 
Number of observations 75 75 77 57 57 54 57 
Notes: * Significant at the 10% level, ** significant at the 5% level, *** significant at the 1% level. 
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Regressions 3.4 to 3.7 explore the relationship between country-level inequality 
and the percentage on HAART.  One of the problems for cross-sectional 
analysis of this kind is that the available data on inequality are relatively limited 
– hence the number of observations falls when measures of inequality are 
included as explanatory variables.  Regression 3.4 re-runs regression 3.3, but 
this time restricted to those countries for which we have data on inequality in 
order to provide an appropriate point of comparison for regressions 3.5 to 3.7.      
As can be seen from regressions 3.5 and 3.6, neither the Gini coefficient nor an 
interaction term multiplying the Gini coefficient with the level of HIV 
prevalence, turned out to have statistically significant coefficients.  Regression 
3.7 tests whether those countries with relatively high levels of HIV prevalence 
(above five percent) and which are located within the 50 percent most unequal 
countries, have lower levels of HAART coverage.  The coefficient on this 
variable also turned out to be statistically insignificant.   
This insignificance of inequality in affecting access to HAART may seem 
surprising.  However, the relationship between inequality and HAART coverage 
is likely to differ from country to country, thereby confounding any aggregate 
statistical relationship.  A negative relationship between inequality and HAART 
coverage may be expected in highly unequal societies where HIV affects the 
poor disproportionately and where elite-dominated governments may be less 
motivated to divert resources towards HAART.  Such countries might also have 
limited health facilities in poor parts of the country (thus limiting access even 
further).  However, HAART coverage is probably positively associated with 
inequality in those countries where inequality is driven primarily by the gap 
between the incomes of the rich and the rest of society, and where the rich have 
access to private health insurance.  Similarly, it is possible that in some unequal 
societies there are a significant number of HIV infections amongst the more 
politically powerful urban constituencies – and if these are not sufficiently 
covered by the private sector, then there will be pressure on government to 
ensure greater access to HAART.   Ultimately, to test the relationship between 
within-country inequality and HAART coverage, we would need more 
disaggregated data – especially on the split between public and private provision 
of HAART, and on the social profile of HIV infections.  Such data is, as yet, 
unavailable.  
Table Four continues the exploratory regression analysis.  In the five regressions 
reported there, all the economic variables and the regional dummies have 
statistically significant coefficients.  One of the reasons for the high HAART 
coverage in Latin America and the Caribbean may have to do with the nature of 
the AIDS epidemic in that region.  Whereas poverty has played a major role in 
Africa’s heterosexual AIDS pandemic (as noted earlier), injecting drug use and 
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gay sex was much more strongly implicated (at least in the initial stages of the 
epidemic) in Latin America (Parker, 2000).  Thus, in the case of Brazil, people 
living with AIDS were more likely to be urban, and many of them middle-class 
and educated – and thus in a better position to fight for greater access to 
HAART than was the case in Africa.  Regressions 4.2 to 4.4. probe whether 
urbanisation itself has any effect on HAART coverage.    
Regression 4.2 includes a variable controlling for the degree of urbanisation.  
However the coefficient on this variable proved statistically insignificant, its 
inclusion in the equation reduced the size and significance of the other 
coefficients and lowered the adjusted R-squared.  Regression 4.3 tries to capture 
the hypothesised urban effect in a different way – i.e. by including the 
differential between urban and rural HIV prevalence.8  The coefficient on this 
variable is statistically significant, but the size effect is small (controlling for the 
other variables, a one percentage point increase in the urban-rural HIV 
prevalence differential results in a 0.1 percent increase in HAART coverage).  
Interestingly, including this variable increased the size effect of the Latin 
American and Caribbean dummy slightly.   
Finally, regressions 4.4 and 4.5 attempt to capture the potential impact of the 
political environment on HAART coverage.  One could hypothesise that the 
greater the ‘space’ for political pressure to be placed on governments, the 
greater the likely level of HAART coverage.  Regression 4.4 includes the World 
Bank’s measure of ‘voice and accountability’.  The sign is in the expected 
direction (the more voice and accountability, the greater the level of HAART 
coverage), but the coefficient is statistically insignificant.  Regression 4.5 
includes a dummy variable taking a value of one if the country is an established 
democracy, and zero if it is not.9  The coefficient on this variable is statistically 
significant at the ten percent level.  It predicts that controlling for the other 
variables, being an established democracy results in a 55 percent increase in 
HAART coverage. 
Note that if the same regression (but including also the (log of) the level of adult 
HIV prevalence) is run on HAART coverage as of June 2004, then neither the 
urban-rural HIV differential nor the democracy dummy variable are statistically 
significant (see regression 4.6).  This suggests that the international effort to 
expand HAART access between June and December 2004 has been 
concentrated in – or has been more successful in achieving its objectives in – 
established democracies.  
                                                 
8 This was estimated by taking the difference between the median HIV prevalence for 
pregnant women in urban and rural areas.  
9  The data for this variable were obtained from Smith (2003).  
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Table Four: Access to HAART: Final Model 




Dependent variable:  Log of HAART 
coverage 






















































































































































    


























































Adjusted R-squared 0.5365 0.5310 0.5538 0.5604 0.5699 0.5457 
Number of observations 77 77 75 75 75 73 
Notes: * Significant at the 10% level, ** significant at the 5% level, *** significant at the 1% level. 
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Using regression 4.5 (the final regression model using December 2004 HAART 
coverage), Figure Four plots the regression residuals, i.e. the actual percentage 
of people on HAART minus the predicted percentage on HAART for each 
country.  Residuals provide a picture of the degree of unexplained variation in 
the model (a model which predicts the actual distribution of people on HAART 
perfectly would have all residuals equal to zero) and provides us with a measure 
of how the various countries perform relative to what one would predict given 
our best available regression model.   
The countries with negative values (most notably the Central African Republic, 
Chad, the Dominican Republic, Kazakhstan, Lesotho, Russia, South Africa, 
Trinidad and Tobago, Tanzania, Vietnam and Zimbabwe) perform worse than 
predicted.  The countries with positive values (most notably Benin, Cameroon, 
Cambodia, Honduras, Indonesia, Malaysia, Senegal, Thailand and Uganda) 
perform better than predicted.  Detailed country-level case studies of these 
countries could potentially shed light on the historical, cultural, social, political 
and institutional conditions that support or hinder HAART coverage.    
3. Conclusion 
This exploratory statistical analysis has highlighted the importance of regional 
and economic factors in understanding the global distribution of country-level 
HAART coverage.  Most notably, the analysis shows that controlling for per 
capita income and other relevant variables, Sub-Saharan African countries have 
better HAART coverage than predicted.     
The analysis presented here has, by its very nature, been unable to account for 
the many historical, social and political factors that affect HAART coverage at 
country level.   It is nevertheless interesting that the simple regression models 
were able to ‘explain’ over half of the variation in the global distribution of the 
percentage of people on HAART (the adjusted R-squared of the final regression 
was 0.57, which is high for cross-country analysis).  This points to the 
continuing importance of underlying structural conditions and the level of 
development in shaping international patterns of HAART coverage.  The 
significance of the economic variables suggest that ensuring greater access to 
HAART requires increased political commitment and sustained growth-
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The CSSR is an umbrella organisation comprising five units:  
 
The Aids and Society Research Unit (ASRU) supports quantitative and 
qualitative research into the social and economic impact of the HIV 
pandemic in Southern Africa.  Focus areas include:  the economics of 
reducing mother to child transmission of HIV, the impact of HIV on firms 
and households; and psychological aspects of HIV infection and 
prevention.  ASRU operates an outreach programme in Khayelitsha (the 
Memory Box Project) which provides training and counselling for HIV 
positive people 
 
The Data First Resource Unit (‘Data First’) provides training and resources 
for research.  Its main functions are: 1) to provide access to digital data 
resources and specialised published material; 2) to facilitate the 
collection, exchange and use of data sets on a collaborative basis; 3) to 
provide basic and advanced training in data analysis; 4) the ongoing 
development of a web site to disseminate data and research output.    
 
The Democracy in Africa Research Unit (DARU) supports students and 
scholars who conduct systematic research in the following three areas:  
1) public opinion and political culture in Africa and its role in 
democratisation and consolidation; 2) elections and voting in Africa; 
and 3) the impact of the HIV/AIDS pandemic on democratisation in 
Southern Africa. DARU has developed close working relationships with 
projects such as the Afrobarometer (a cross national survey of public 
opinion in fifteen African countries), the Comparative National Elections 
Project, and the Health Economics and AIDS Research Unit at the 
University of Natal. 
 
The Social Surveys Unit (SSU) promotes critical analysis of the 
methodology, ethics and results of South African social science 
research. One core activity is the Cape Area Panel Study of young 
adults in Cape Town.  This study follows 4800 young people as they 
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planning a survey for 2004 on aspects of social capital, crime, and 
attitudes toward inequality. 
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the CSSR in 2002.  SALDRU conducted the first national household survey 
in 1993 (the Project for Statistics on Living Standards and Development).  
More recently, SALDRU ran the Langeberg Integrated Family survey 
(1999) and the Khayelitsha/Mitchell’s Plain Survey (2000).  Current 
projects include research on public works programmes, poverty and 
inequality.  
 
 
 
